[
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Liver-on-Chip",
    "Organs/Tissues": "Human liver parenchyma (hepatocytes) in microfluidic wells",
    "Physiological/Pathological": "Normal liver metabolism; can model drug-induced liver injury, steatosis",
    "Cell Source": "Primary human hepatocytes or iPSC-derived hepatic cells, co-cultures possible",
    "Multiple Cell Types": "Yes if including non-parenchymal liver cells (stellate, Kupffer) or typically at least hepatocytes",
    "Stromal Cells": "Optional; can add stellate cells for fibrosis studies",
    "Tissue-resident Immune": "Possible if Kupffer cells are co-cultured, not standard by default",
    "Circulating Immune": "No (unless introduced in a multi-organ circuit or advanced model)",
    "Crosstalk (Multi-tissue)": "Yes, can link to other organ chips on PREDICT96 if desired",
    "Air-Liquid Interface": "No (liver model fully perfused)",
    "Extracellular Matrix": "Collagen or Matrigel in 3D microchambers or membrane-based culture",
    "3D Scaffold": "Yes, 3D hepatic microtissues or sandwich cultures under flow",
    "Notable Features": "Metabolic function, drug toxicity screening under perfusion, integrated TEER sensors, small-volume recirculation",
    "Plate/Format (Throughput)": "PREDICT96 plate – 96 wells with microfluidic flow, mid–high throughput",
    "Max Culture Duration": "Up to ~2–3 weeks stable liver function",
    "Readouts - Live Imaging": "Yes (transparent wells for microscopy)",
    "Readouts - Supernatant Sampling": "Yes (perfusate from each well), measure albumin, urea, etc.",
    "Readouts - Cell Retrieval": "Yes (harvest cells/tissues at endpoint)",
    "Readouts - Whole Tissue": "Yes, fix/stain entire hepatic microtissue",
    "Readouts - TEER": "Yes, can measure barrier or epithelial integrity if co-culture used",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "O₂, TEER, possibly other sensors for real-time monitoring",
    "Dead Volume": "Low (~microliters) microfluidic well volumes",
    "Perfused": "Yes, built-in recirculating flow in each well",
    "Gas Mix Controlled": "Incubator environment",
    "Real-time Microenvironment Control": "Programmable flow rates & drug dosing in each of 96 wells",
    "model_availability": "Used in Draper’s internal or partner collaborations, not sold as a standalone kit"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Kidney-on-Chip",
    "Organs/Tissues": "Human renal proximal tubule epithelium (co-culture with endothelium possible)",
    "Physiological/Pathological": "Normal reabsorptive function; can model nephrotoxicity (drug-induced kidney injury)",
    "Cell Source": "Primary kidney epithelial cells or iPSC-derived renal cells in 3D microchambers",
    "Multiple Cell Types": "Yes if endothelium or fibroblasts are added for tubulovascular unit",
    "Stromal Cells": "Not standard but feasible (renal fibroblasts in interstitium)",
    "Tissue-resident Immune": "Possible but not typical in baseline model",
    "Circulating Immune": "No (unless added for infiltration studies)",
    "Crosstalk (Multi-tissue)": "Yes, can link to other organs (e.g. liver) on the same platform",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes, collagen or basement membrane coatings on porous membrane",
    "3D Scaffold": "Yes, tubule-like structure under flow or 3D epithelium on membrane",
    "Notable Features": "Renal transporter function, dynamic fluid shear, measure toxicity or reabsorption",
    "Plate/Format (Throughput)": "PREDICT96 multi-well, moderate-high throughput (96 parallel units)",
    "Max Culture Duration": "Days to ~2 weeks stable function",
    "Readouts - Live Imaging": "Yes, can visualize tubule cell morphology, fluorescent transport assays",
    "Readouts - Supernatant Sampling": "Yes, to measure reabsorbed vs. secreted compounds",
    "Readouts - Cell Retrieval": "Yes, endpoint cell analysis possible",
    "Readouts - Whole Tissue": "Yes, fix/stain for transporters or tight junctions",
    "Readouts - TEER": "Yes, to gauge barrier tightness of tubule epithelium",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "O₂, TEER integrated, can measure permeability in real time",
    "Dead Volume": "Very low, ensuring accurate drug concentration",
    "Perfused": "Yes, recirculating flow in each well to mimic tubular fluid",
    "Gas Mix Controlled": "Incubator-based",
    "Real-time Microenvironment Control": "Flow/dosing programmable in each well",
    "model_availability": "Used by Draper in collaborative R&D projects"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Gut/Colon-on-Chip",
    "Organs/Tissues": "Human colon/intestinal epithelial barrier (primary stem-cell derived)",
    "Physiological/Pathological": "Healthy barrier function for drug absorption, can model inflammation (IBD-like) or infection",
    "Cell Source": "Primary human colon epithelial stem cells, 3D or monolayer on porous membrane",
    "Multiple Cell Types": "Yes if co-cultured with fibroblasts/immune cells; standard is epithelial",
    "Stromal Cells": "Optional sub-epithelial fibroblasts in separate channel for more realistic gut mucosa",
    "Tissue-resident Immune": "Possible to add if modeling inflamed gut, not default",
    "Circulating Immune": "No, not standard, though infiltration can be tested in advanced setups",
    "Crosstalk (Multi-tissue)": "Yes, can link to other organ chips (liver, etc.) to mimic gut-liver axis",
    "Air-Liquid Interface": "No, though some alveolar chips use ALI, but colon typically a fluid–fluid system with luminal flow",
    "Extracellular Matrix": "Yes, basement membrane or hydrogel around epithelial cells",
    "3D Scaffold": "Epithelial barrier forms a 2D monolayer, can form crypt-like structures in 3D expansions",
    "Notable Features": "High TEER values, stable differentiation ~11+ days, drug permeability testing",
    "Plate/Format (Throughput)": "PREDICT96 microfluidic plate (96 wells)",
    "Max Culture Duration": "~2 weeks or more to see stable function",
    "Readouts - Live Imaging": "Yes, imaging cell morphology, tight junctions, etc.",
    "Readouts - Supernatant Sampling": "Yes, measure secreted cytokines, drug absorption rates",
    "Readouts - Cell Retrieval": "Yes, endpoint gene expression or microbial co-culture analysis",
    "Readouts - Whole Tissue": "Yes, fix and stain entire barrier in each well",
    "Readouts - TEER": "Yes, integrated impedance sensors track barrier integrity",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER, optionally O₂",
    "Dead Volume": "Minimal microfluidic volume",
    "Perfused": "Yes, recirculating flow over apical & basal channels for nutrient/gas exchange",
    "Gas Mix Controlled": "Incubator-based",
    "Real-time Microenvironment Control": "Flow/dosing per well programmable; can trigger inflammatory stimuli",
    "model_availability": "Internal use & partner projects"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Lung Airway-on-Chip",
    "Organs/Tissues": "Human bronchial or alveolar epithelial cells, sometimes co-cultured with fibroblasts/endothelium",
    "Physiological/Pathological": "Healthy airway with mucociliary function; can simulate infection (e.g. SARS-CoV-2) or toxic inhalation",
    "Cell Source": "Primary human bronchial epithelial cells, iPSC-lung cells. ALI culture for mucociliary differentiation",
    "Multiple Cell Types": "Yes (epithelium + stromal or endothelial). Immune cells if inflamed model",
    "Stromal Cells": "Possible fibroblasts in basolateral compartment",
    "Tissue-resident Immune": "Not standard, but alveolar macrophages could be introduced",
    "Circulating Immune": "No, not standard unless multi-organ linking with flow of immune cells",
    "Crosstalk (Multi-tissue)": "Yes, can combine with other organs in PREDICT96",
    "Air-Liquid Interface": "Yes, apical side with air exposure, basal side with perfused medium",
    "Extracellular Matrix": "Epithelial layer on membrane with ECM coating",
    "3D Scaffold": "Pseudo-3D, cells form layered epithelium at ALI. Spheroids or alveolar bud also feasible",
    "Notable Features": "Mucociliary differentiation, infection studies (COVID-19 demonstration), real-time TEER for barrier",
    "Plate/Format (Throughput)": "PREDICT96 plate, 96 microfluidic wells with ALI capability",
    "Max Culture Duration": "1–3+ weeks, enough for full ciliation & infection assays",
    "Readouts - Live Imaging": "Yes (immunofluorescence, cilia beating observation)",
    "Readouts - Supernatant Sampling": "Yes, measure secreted mucus, cytokines, viral load if infected",
    "Readouts - Cell Retrieval": "Yes at endpoint (scrape or detach epithelium)",
    "Readouts - Whole Tissue": "Yes, fix & stain alveolar or bronchial layer on membrane",
    "Readouts - TEER": "Yes, barrier measurement for alveolar/airway integrity",
    "Readouts - MEA": "No (not relevant to non-excitable epithelium)",
    "Readouts - Integrated Biosensors": "TEER, possible O₂. Infectivity or mechanical sensors if custom",
    "Dead Volume": "Minimal fluid channels",
    "Perfused": "Yes, basolateral perfusion while apical is air side",
    "Gas Mix Controlled": "Incubator. Apical side is air, can introduce aerosol or pathogens",
    "Real-time Microenvironment Control": "Flow and dosing in each well programmable. Infectious agent introduction, etc.",
    "model_availability": "In-house at Draper or partner labs"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Vascular Endothelium Model",
    "Organs/Tissues": "Human endothelial cells forming microvascular channels under shear",
    "Physiological/Pathological": "Normal vascular barrier or disease states (inflammation, permeability changes)",
    "Cell Source": "Primary human endothelial cells (HUVEC, microvascular) or iPSC-derived vascular cells",
    "Multiple Cell Types": "Can co-culture with pericytes or smooth muscle cells if desired",
    "Stromal Cells": "Optional (vascular smooth muscle or fibroblasts)",
    "Tissue-resident Immune": "No, though could add monocytes for adhesion/transmigration",
    "Circulating Immune": "Yes if perfused in the channel to study rolling/adhesion (similar to inflammation chip style)",
    "Crosstalk (Multi-tissue)": "Yes, can link to parenchymal organ modules on PREDICT96",
    "Air-Liquid Interface": "No (endothelium is fully liquid perfusion)",
    "Extracellular Matrix": "Collagen- or fibronectin-coated membrane for endothelial adherence",
    "3D Scaffold": "2D monolayer forming 3D micro-channel geometry",
    "Notable Features": "Shear flow for physiological endothelium, measure vascular permeability or immune cell adhesion",
    "Plate/Format (Throughput)": "PREDICT96 microfluidic plate",
    "Max Culture Duration": "Days to ~2 weeks with stable barrier properties",
    "Readouts - Live Imaging": "Yes, watch cell alignment, morphology under flow",
    "Readouts - Supernatant Sampling": "Yes, measure secreted cytokines, track flow outputs",
    "Readouts - Cell Retrieval": "Yes, can be harvested for gene expression or protein assays",
    "Readouts - Whole Tissue": "Yes, fix/stain endothelium in the channel",
    "Readouts - TEER": "Yes, measure endothelium tightness or barrier function",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER, possibly O₂ or other sensors if used",
    "Dead Volume": "Very low channel volume",
    "Perfused": "Yes, mechanical shear replicates blood flow",
    "Gas Mix Controlled": "Incubator environment",
    "Real-time Microenvironment Control": "User can vary flow rates, add immune cells or inflammatory stimuli",
    "model_availability": "Collaborative development with Draper"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Gingival (Oral) Model",
    "Organs/Tissues": "Human gingival tissue (epithelial + fibroblasts + possibly immune) on-chip",
    "Physiological/Pathological": "Healthy oral mucosa or periodontitis-like inflammation under flow",
    "Cell Source": "Primary human oral epithelial cells, gingival fibroblasts, plus optional immune cells",
    "Multiple Cell Types": "Yes (3D co-culture of epithelial + fibroblast + optional immune support)",
    "Stromal Cells": "Yes, fibroblasts in sub-epithelial layer for normal gum tissue",
    "Tissue-resident Immune": "Possible inclusion of macrophages or dendritic cells for inflammatory models",
    "Circulating Immune": "No standard, but can be introduced if needed",
    "Crosstalk (Multi-tissue)": "Yes, if linking with other tissues in multi-organ approach",
    "Air-Liquid Interface": "Typically no, though partial ALI if simulating mouth surface; Draper references perfused but not full ALI",
    "Extracellular Matrix": "Epithelial layer on membrane with fibroblasts in collagen underneath",
    "3D Scaffold": "Yes, creating layered oral mucosa structure in 3D",
    "Notable Features": "Long-term viability (~28 days reported), responds to pro-inflammatory stimuli, mimics oral barrier function",
    "Plate/Format (Throughput)": "PREDICT96 plate, 96 parallel tissues",
    "Max Culture Duration": "~4 weeks stable function",
    "Readouts - Live Imaging": "Yes, can visualize epithelial layer, fibroblast interactions",
    "Readouts - Supernatant Sampling": "Yes, measure inflammatory cytokines or secreted factors",
    "Readouts - Cell Retrieval": "Yes, at endpoint for histology or gene expression",
    "Readouts - Whole Tissue": "Yes, fix entire 3D oral tissue for morphological analysis",
    "Readouts - TEER": "Yes, track mucosal barrier integrity",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER, possibly O₂. Real-time monitoring of barrier changes",
    "Dead Volume": "Low microfluidic environment",
    "Perfused": "Yes, media flow for nutrient supply/waste removal",
    "Gas Mix Controlled": "Incubator (5% CO₂, 37°C)",
    "Real-time Microenvironment Control": "Flow/dosing changes, applying bacterial or inflammatory triggers",
    "model_availability": "Used by Draper & partners (e.g. Colgate-Palmolive) in R&D"
  },
  {
    "Company": "Draper",
    "Model": "PREDICT96 – Tumor-on-Chip",
    "Organs/Tissues": "3D human tumor microtissues (cancer cells ± stroma) in perfused microfluidic wells",
    "Physiological/Pathological": "Pathological (cancer). Testing drug efficacy, invasion, metastasis modeling",
    "Cell Source": "Patient-derived tumor cells, cell lines, or iPSC-derived tumor-like cells; co-culture with fibroblasts or endothelium optional",
    "Multiple Cell Types": "Yes, often tumor cells + stromal fibroblasts + optional endothelium",
    "Stromal Cells": "Yes, can add CAFs or normal fibroblasts for realistic tumor microenvironment",
    "Tissue-resident Immune": "Not standard, but can be introduced for immuno-oncology studies",
    "Circulating Immune": "No, unless specifically added for infiltration experiments",
    "Crosstalk (Multi-tissue)": "Yes, can be combined with other organ chips for metastasis or systemic toxicity",
    "Air-Liquid Interface": "No, immersed 3D tumor spheroids",
    "Extracellular Matrix": "Yes, matrix (collagen, Matrigel) for 3D tumor growth",
    "3D Scaffold": "Yes, 3D spheroids or organoids in microchamber under flow",
    "Notable Features": "Perfused microenvironment for nutrient/drug delivery, can measure tumor growth, viability, invasion under real-time observation",
    "Plate/Format (Throughput)": "PREDICT96, 96 parallel tumor cultures",
    "Max Culture Duration": "Days to ~2 weeks for typical tumor assay timelines",
    "Readouts - Live Imaging": "Yes (confocal or plate-based imaging, measure size, invasion, viability)",
    "Readouts - Supernatant Sampling": "Yes, track secreted factors, drug metabolism by tumor",
    "Readouts - Cell Retrieval": "Yes, can retrieve tumor for endpoint molecular analysis",
    "Readouts - Whole Tissue": "Yes, fix/stain entire 3D tumor model",
    "Readouts - TEER": "No (unless endothelium is integrated to measure vascular barrier)",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "Possible O₂ or pH sensors. Not default, but feasible",
    "Dead Volume": "Low microfluidic environment, ensuring local drug exposure",
    "Perfused": "Yes, recirculating flow feeding tumor microtissue",
    "Gas Mix Controlled": "Incubator-based",
    "Real-time Microenvironment Control": "Flow/dosing adjustable to mimic therapy schedules, can do combination treatments",
    "model_availability": "In-house development at Draper or collaborative partner usage"
  }
]
